Open access
Open access
Powered by Google Translator Translator

Internal Medicine

Management of anosmia and loss of smell in the era of Covid-19

27 Jul, 2020 | 09:51h | UTC

Anosmia and loss of smell in the era of covid-19 – The BMJ

 


Particle sizes of infectious aerosols: Implications for infection control

27 Jul, 2020 | 09:43h | UTC

Particle sizes of infectious aerosols: implications for infection control – The Lancet Respiratory Medicine

 


[Abstract Only] Randomized trial: Fluoxetine does not improve functional recovery after acute stroke

27 Jul, 2020 | 09:35h | UTC

Safety and efficacy of fluoxetine on functional recovery after acute stroke (EFFECTS): a randomised, double-blind, placebo-controlled trial – The Lancet Neurology

Commentary: Antidepressant does not improve post-stroke recovery – Karolinska Institutet

 


Review: Perioperative cardiovascular risk assessment and management for noncardiac surgery

27 Jul, 2020 | 09:32h | UTC

Perioperative Cardiovascular Risk Assessment and Management for Noncardiac Surgery: A Review – JAMA (free for a limited period)

 

Related Commentary on Twitter

 


Coalition Covid-19 Brazil – Randomized trial: hydroxychloroquine with or without azithromycin in mild-to-moderate Covid-19

24 Jul, 2020 | 09:37h | UTC

Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19 – New England Journal of Medicine

Commentary: Another study finds hydroxychloroquine does not help Covid-19 patients – CNN

 


Epidemiology of and risk factors for coronavirus infection in health care workers

24 Jul, 2020 | 09:27h | UTC

Epidemiology of and Risk Factors for Coronavirus Infection in Health Care Workers: A Living Rapid Review – Annals of Internal Medicine

 


Mask mandates and other lockdown policies reduced the spread of COVID-19 in the US

24 Jul, 2020 | 09:21h | UTC

Mask mandates and other lockdown policies reduced the spread of COVID-19 in the US – World Economic Forum

 


Meta-analysis: Bacterial co-infection and secondary infection in patients with COVID-19

24 Jul, 2020 | 09:26h | UTC

Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis – Clinical Microbiology and Infection

 


We asked coronavirus experts when they’ll hug, pub and fly again

24 Jul, 2020 | 09:19h | UTC

We asked coronavirus experts when they’ll hug, pub and fly again – Wired

 


Meta-analysis of prospective cohort studies: Dietary intake of total, animal, and plant proteins and risk of all cause, cardiovascular, and cancer mortality

24 Jul, 2020 | 09:15h | UTC

Dietary intake of total, animal, and plant proteins and risk of all cause, cardiovascular, and cancer mortality: systematic review and dose-response meta-analysis of prospective cohort studies – The BMJ

 


Audio interview: Dexamethasone and Covid-19

23 Jul, 2020 | 08:44h | UTC

Audio Interview: Dexamethasone and Covid-19 – New England Journal of Medicine

 


Observational study: Glucocorticoid treatment linked to reduced mortality in patients with Covid-19 and initial C-reactive protein ≥20 mg/dL

23 Jul, 2020 | 08:49h | UTC

Effect of Systemic Glucocorticoids on Mortality or Mechanical Ventilation in Patients With COVID-19 – Journal of Hospital Medicine

Commentaries: A blood test may show which COVID-19 patients steroids will help — or harm – Science News AND Common blood test identifies benefits and risks of steroid treatment in COVID-19 patients – Albert Einstein College of Medicine

 


Perspective: Managing uncertainty in the Covid-19 era

23 Jul, 2020 | 08:48h | UTC

Managing uncertainty in the covid-19 era – The BMJ Opinion

 


COVID-19 serological tests: how well do they actually perform?

23 Jul, 2020 | 08:31h | UTC

COVID-19 Serological Tests: How Well Do They Actually Perform? – Diagnostics

Commentary: Overview of Covid-19 Serological Tests – MedicalResearch.com

 


Fasting blood glucose at admission as a predictor for mortality in patients with COVID-19 without previous diagnosis of diabetes

23 Jul, 2020 | 08:28h | UTC

Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study – Diabetologia

Commentaries: Study links abnormally high blood sugar with higher risk of death in COVID-19 patients not previously diagnosed with diabetes – Diabetologia AND Expert reaction to study looking at blood sugar level and death in hospitalised COVID-19 patients in Wuhan – Science Media Centre

 


Placebos in chronic pain: evidence, theory, ethics, and use in clinical practice

23 Jul, 2020 | 08:22h | UTC

Placebos in chronic pain: evidence, theory, ethics, and use in clinical practice – The BMJ (free for a limited period)

 


Chest CT in COVID-19 pneumonia: A review of current knowledge

23 Jul, 2020 | 08:27h | UTC

Chest CT in COVID-19 pneumonia: A review of current knowledge – Diagnostic and Interventional Imaging

 


Management and prevention of anemia (acute bleeding excluded) in adult critical care patients

23 Jul, 2020 | 08:21h | UTC

Management and prevention of anemia (acute bleeding excluded) in adult critical care patients – Annals of Intensive Care

 


Rapid decay of Anti–SARS-CoV-2 antibodies in persons with mild Covid-19

22 Jul, 2020 | 02:35h | UTC

Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19 – New England Journal of Medicine

 


Medication management in frail older people: Consensus principles for clinical practice, research, and education

22 Jul, 2020 | 02:17h | UTC

Medication Management in Frail Older People: Consensus Principles for Clinical Practice, Research, and Education – Journal of Post-Acute and Long-Term Care Medicine

News Release: Monash University researchers develop new international consensus principles for medicines management in frail older people

 


[Abstract Only] Meta-analysis: association of delirium with long-term cognitive decline

22 Jul, 2020 | 02:12h | UTC

Association of Delirium With Long-term Cognitive Decline: A Meta-analysis – JAMA Neurology

Commentary: Delirium linked to long-term cognitive decline – News Medical

 


Canadian Cardiovascular Society position statement on pulmonary hypertension

22 Jul, 2020 | 02:14h | UTC

Canadian Cardiovascular Society/Canadian Thoracic Society Position Statement on Pulmonary Hypertension – Canadian Journal of Cardiology

 


Phase 2 randomized trial: immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults

21 Jul, 2020 | 09:29h | UTC

Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial – The Lancet

Commentaries: China’s Ad5 vectored COVID-19 vaccine safe and induces immune response – News Medical AND CanSino COVID-19 vaccine generates immune response in 90% of patients – UPI

 

Related Commentary on Twitter

https://twitter.com/TheLancet/status/1285209554775617536

 


Editorial: encouraging results from phase 1/2 COVID-19 vaccine trials

21 Jul, 2020 | 09:35h | UTC

Encouraging results from phase 1/2 COVID-19 vaccine trials – The Lancet

Podcast: The Lancet Editor-in-Chief Richard Horton explains the current status of the Oxford and China COVID-19 vaccines

Commentaries: Promising early findings for 2 more COVID-19 vaccines – CIDRAP AND Expert reaction to two vaccine candidate studies: a phase 1/2 trial of the University of Oxford’s ChAdOx1 vaccine candidate; and a phase 2 trial of China’s Ad5-vectored COVID-19 vaccine candidate – Science Media Centre

 


[Press release-based medicine…] Synairgen announces positive results from trial of SNG001 in hospitalized COVID-19 patients

21 Jul, 2020 | 09:27h | UTC

Synairgen announces positive results from trial of SNG001 in hospitalised COVID-19 patients

Commentaries: New Treatment for Covid-19 Shows Promise, but Scientists Urge Caution – The New York Times AND Expert reaction to announcement by Synairgen that their drug SNG001 has had positive results in initial trials on COVID-19 patients – Science Media Centre AND Trial of Covid-19 drug given via inhaler ‘very promising’, say scientists – The Guardian

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.